“We’ve entered the age of precision medicine, where treatments are increasingly based on individual genetic profiles,” says Dr. Yaw Bediako to CancerWorld, immunologist and founder of Yemaachi. “But many of these solutions are least effective in African populations simply because we’re not included in the datasets they’re built on.
The African Cancer Atlas is envisioned as a foundational resource for scientists and clinicians working to understand cancer in African populations. By expanding the diversity of tumor genomic data, TACA aims to inform the development of more accurate diagnostics, predictive tools, and targeted therapies that work better across global populations, not just those of European ancestry.”
Read the full article here: Cancer World